Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Modification of high-density lipoprotein functions by diet and other lifestyle changes: A systematic review of randomized controlled trials

  • Sanllorente Melenchon, Albert
  • Lassale, Camille
  • Soria Florido, María Trinidad
  • Castañer, Olga
  • Fitó Colomer, Montserrat
  • Hernáez, Álvaro
High-density lipoprotein (HDL) functional traits have emerged as relevant elements that may explain HDL antiatherogenic capacity better than HDL cholesterol levels. These properties have been improved in several lifestyle intervention trials. The aim of this systematic review is to summarize the results of such trials of the most commonly used dietary modifications (fatty acids, cholesterol, antioxidants, alcohol, and calorie restriction) and physical activity. Articles were screened from the Medline database until March 2021, and 118 randomized controlled trials were selected. Results from HDL functions and associated functional components were extracted, including cholesterol efflux capacity, cholesteryl ester transfer protein, lecithin-cholesterol acyltransferase, HDL antioxidant capacity, HDL oxidation status, paraoxonase-1 activity, HDL anti-inflammatory and endothelial protection capacity, HDL-associated phospholipase A2, HDL-associated serum amyloid A, and HDL-alpha-1-antitrypsin. In mainly short-term clinical trials, the consumption of monounsaturated and polyunsaturated fatty acids (particularly omega-3 in fish), and dietary antioxidants showed benefits to HDL functionality, especially in subjects with cardiovascular risk factors. In this regard, antioxidant-rich dietary patterns were able to improve HDL function in both healthy individuals and subjects at high cardiovascular risk. In addition, in randomized trial assays performed mainly in healthy individuals, reverse cholesterol transport with ethanol in moderate quantities enhanced HDL function. Nevertheless, the evidence summarized was of unclear quality and short-term nature and presented heterogeneity in lifestyle modifications, trial designs, and biochemical techniques for the assessment of HDL functions. Such findings should therefore be interpreted with caution. Large-scale, long-term, randomized, controlled trials in different populations and individuals with diverse pathologies are warranted., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Sourdough bread with different fermentation times: A randomized clinical trial in subjects with metabolic syndrome

  • Pérez-Vega, Karla Alejandra
  • Sanllorente Melenchon, Albert
  • Zomeño, M. Dolores
  • Quindós, Ana
  • Muñoz-Martínez, Júlia
  • Malcampo, Mireia
  • Aldea-Perona, Ana
  • Hernáez, Álvaro
  • Lluansí, Aleix
  • Llirós, Marc
  • Elias, Isidre
  • Elias Masiques, Núria
  • Aldeguer, Xavier
  • Muñoz, Daniel
  • Gaixas Vasallo, Sònia
  • Blanchart, Gemma
  • Schröder, Helmut
  • Hernando Redondo, Javier
  • Carrón, Nerea
  • González-Torres, Pedro
  • Konstantinidou, Valentini
  • Fitó Colomer, Montserrat
  • Castañer, Olga
The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabolic syndrome. In a double-blind clinical trial, participants were randomized to consume either Elias Boulanger® long-fermentation (48 h) sourdough bread (EBLong) or Elias Boulanger® short-fermentation (2 h) sourdough bread (EBShort) over a two-month period. We assessed clinical parameters, inflammatory biomarkers, satiety-related hormones, and the richness and abundance of gut microbiota at baseline and follow-up. The participants included 31 individuals (mean age, 67, 51.6% female). EBShort was associated with reduced levels of soluble intercellular adhesion molecule (sICAM), and all participants, regardless of the intervention, exhibited a decrease in sICAM and diastolic pressure from baseline (p < 0.017). At follow-up, plasminogen activator inhibitor-1 (PAI-1) levels were lower in EBShort (−744 pg/mL; 95%CI: −282 to −1210 pg/mL) compared to EBLong. No differences in microbiota richness or abundance were observed. EBShort bread was effective in reducing some inflammation markers. The consumption of sourdough bread may offer potential benefits in reducing inflammation markers in individuals with metabolic syndrome; however, longer fermentation times did not show additional benefits., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Resemblance of the human liver sinusoid in a fluidic device with biomedical and pharmaceutical applications

  • Ortega-Ribera, Martí
  • Fernández-Iglesias, Anabel
  • Illa, Xavi
  • Moya, Ana
  • Molina, Víctor
  • Maeso-Díaz, Raquel
  • Fondevila, Constantino
  • Peralta, Carmen
  • Bosch, Jaume
  • Villa, Rosa
  • Gracia-Sancho, Jordi
Maintenance of the complex phenotype of primary hepatocytes in vitro represents a limitation for developing liver support systems and reliable tools for biomedical research and drug screening. We herein aimed at developing a biosystem able to preserve human and rodent hepatocytes phenotype in vitro based on the main characteristics of the liver sinusoid: unique cellular architecture, endothelial biodynamic stimulation, and parenchymal zonation. Primary hepatocytes and liver sinusoidal endothelial cells (LSEC) were isolated from control and cirrhotic human or control rat livers and cultured in conventional in vitro platforms or within our liver-resembling device. Hepatocytes phenotype, function, and response to hepatotoxic drugs were analyzed. Results evidenced that mimicking the in vivo sinusoidal environment within our biosystem, primary human and rat hepatocytes cocultured with functional LSEC maintained morphology and showed high albumin and urea production, enhanced cytochrome P450 family 3 subfamily A member 4 (CYP3A4) activity, and maintained expression of hepatocyte nuclear factor 4 alpha (hnf4α) and transporters, showing delayed hepatocyte dedifferentiation. In addition, differentiated hepatocytes cultured within this liver-resembling device responded to acute treatment with known hepatotoxic drugs significantly different from those seen in conventional culture platforms. In conclusion, this study describes a new bioengineered device that mimics the human sinusoid in vitro, representing a novel method to study liver diseases and toxicology., Funding text 1 This study was carried out at the Esther Koplowitz Center—IDIBAPS. The fabrication of Exoliver was performed by the platform of Production of Biomaterials and Biomolecules of the ICTS “NANBIOSIS,” more specifically by the U8 Unit of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBERBBN) at the IMB-CNM (CSIC). Authors are indebted to Nicolò Manicardi, Sergi Guixé, and Sergi Vila from IDIBAPS for their skilled assistance. The authors thank current and former members of the GAB Lab and specially Jose Yeste, Gemma Gabriel, and Maria Navarro for their assistance and critical discussions during the development of this study. This work was supported by the Spanish Ministry of Economy, Industry and Competitivity (Explora Project BIO2014-61377 to J. Gracia-Sancho), CSIC (PIE-201450E116 to R. Villa), the CaixaImpulse Program (CI16/00052), Instituto de Salud Carlos III (FIS PI17/00012 to J. Gracia-Sancho), the European Union FEDER Funds, “una manera de hacer Europa,” and the CERCA Program from the Generalitat de Catalunya. CIBEREHD and CIBERBBN are funded by Instituto de Salud Carlos III. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. Ortega-Ribera and R. Maeso-Díaz received a fellowship from the Instituto de Salud Carlos III (iPFIS IFI16/00016 and iPFIS IFI15/00037, respectively). A. Fernández-Iglesias has a Sara Borrell contract from the Instituto de Salud Carlos III (CD15/00050). Funding text 2 Ministerio de Ciencia, Innovación y Universidades, Grant/Award Number: Explora BIO2014‐61377; CSIC, Grant/Award Number: PIE‐201450E116; Instituto de Salud Carlos III, Grant/Award Numbers: iPFIS IFI15/00037, iPFIS IFI16/00016, CD15/00050, FIS PI17/ 00012; European Union FEDER Funds; Generalitat de Catalunya; CaixaImpulse Program, Grant/Award Number: CI16/00052 Funding text 3 This work was supported by the Spanish Ministry of Economy, Industry and Competitivity (Explora Project BIO2014‐61377 to J. Gracia‐Sancho), CSIC (PIE‐201450E116 to R. Villa), the CaixaIm-pulse Program (CI16/00052), Instituto de Salud Carlos III (FIS PI17/ 00012 to J. Gracia‐Sancho), the European Union FEDER Funds, “una manera de hacer Europa,” and the CERCA Program from the Generalitat de Catalunya. CIBEREHD and CIBERBBN are funded by Instituto de Salud Carlos III. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. Ortega‐Ribera and R. Maeso‐Díaz received a fellowship from the Instituto de Salud Carlos III (iPFIS IFI16/00016 and iPFIS IFI15/00037, respectively). A. Fernández‐Iglesias has a Sara Borrell contract from the Instituto de Salud Carlos III (CD15/00050)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Modification of high-density lipoprotein functions by diet and other lifestyle changes: A systematic review of randomized controlled trials

  • Sanllorente Melenchon, Albert
  • Lassale, Camille
  • Soria Florido, María Trinidad
  • Castañer, Olga
  • Fitó Colomer, Montserrat
  • Hernáez, Álvaro
High-density lipoprotein (HDL) functional traits have emerged as relevant elements that may explain HDL antiatherogenic capacity better than HDL cholesterol levels. These properties have been improved in several lifestyle intervention trials. The aim of this systematic review is to summarize the results of such trials of the most commonly used dietary modifications (fatty acids, cholesterol, antioxidants, alcohol, and calorie restriction) and physical activity. Articles were screened from the Medline database until March 2021, and 118 randomized controlled trials were selected. Results from HDL functions and associated functional components were extracted, including cholesterol efflux capacity, cholesteryl ester transfer protein, lecithin-cholesterol acyltransferase, HDL antioxidant capacity, HDL oxidation status, paraoxonase-1 activity, HDL anti-inflammatory and endothelial protection capacity, HDL-associated phospholipase A2, HDL-associated serum amyloid A, and HDL-alpha-1-antitrypsin. In mainly short-term clinical trials, the consumption of monounsaturated and polyunsaturated fatty acids (particularly omega-3 in fish), and dietary antioxidants showed benefits to HDL functionality, especially in subjects with cardiovascular risk factors. In this regard, antioxidant-rich dietary patterns were able to improve HDL function in both healthy individuals and subjects at high cardiovascular risk. In addition, in randomized trial assays performed mainly in healthy individuals, reverse cholesterol transport with ethanol in moderate quantities enhanced HDL function. Nevertheless, the evidence summarized was of unclear quality and short-term nature and presented heterogeneity in lifestyle modifications, trial designs, and biochemical techniques for the assessment of HDL functions. Such findings should therefore be interpreted with caution. Large-scale, long-term, randomized, controlled trials in different populations and individuals with diverse pathologies are warranted., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sourdough bread with different fermentation times: A randomized clinical trial in subjects with metabolic syndrome

  • Pérez-Vega, Karla Alejandra
  • Sanllorente Melenchon, Albert
  • Zomeño, M. Dolores
  • Quindós, Ana
  • Muñoz-Martínez, Júlia
  • Malcampo, Mireia
  • Aldea-Perona, Ana
  • Hernáez, Álvaro
  • Lluansí, Aleix
  • Llirós, Marc
  • Elias, Isidre
  • Elias Masiques, Núria
  • Aldeguer, Xavier
  • Muñoz, Daniel
  • Gaixas Vasallo, Sònia
  • Blanchart, Gemma
  • Schröder, Helmut
  • Hernando Redondo, Javier
  • Carrón, Nerea
  • González-Torres, Pedro
  • Konstantinidou, Valentini
  • Fitó Colomer, Montserrat
  • Castañer, Olga
The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabolic syndrome. In a double-blind clinical trial, participants were randomized to consume either Elias Boulanger® long-fermentation (48 h) sourdough bread (EBLong) or Elias Boulanger® short-fermentation (2 h) sourdough bread (EBShort) over a two-month period. We assessed clinical parameters, inflammatory biomarkers, satiety-related hormones, and the richness and abundance of gut microbiota at baseline and follow-up. The participants included 31 individuals (mean age, 67, 51.6% female). EBShort was associated with reduced levels of soluble intercellular adhesion molecule (sICAM), and all participants, regardless of the intervention, exhibited a decrease in sICAM and diastolic pressure from baseline (p < 0.017). At follow-up, plasminogen activator inhibitor-1 (PAI-1) levels were lower in EBShort (−744 pg/mL; 95%CI: −282 to −1210 pg/mL) compared to EBLong. No differences in microbiota richness or abundance were observed. EBShort bread was effective in reducing some inflammation markers. The consumption of sourdough bread may offer potential benefits in reducing inflammation markers in individuals with metabolic syndrome; however, longer fermentation times did not show additional benefits., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gene amplification-associated overexpression of the selenoprotein trna enzyme trit1 confers sensitivity to arsenic trioxide in small-cell lung cancer

  • Coll-Sanmartin, Laia
  • Davalos, Veronica|||0000-0003-4077-5137
  • Piñeyro, David|||0000-0001-5633-3339
  • Rosselló-Tortella, Margalida|||0000-0003-4610-7981
  • Bueno-Costa, Alberto|||0000-0001-8700-2540
  • Setien, Fernando|||0000-0002-4061-4635
  • Villanueva, Alberto|||0000-0001-5164-0006
  • Granada, Isabel|||0000-0002-4275-0104
  • Ruiz-Xiviller, Neus
  • Kotter, Annika
  • Helm, Mark|||0000-0002-0154-0928
  • Yokota, Jun|||0000-0001-6010-6294
  • Kawabata-Iwakawa, Reika|||0000-0002-3504-1393
  • Kohno, Takashi|||0000-0002-5371-706X
  • Esteller, M.|||0000-0003-4490-6093